market growth share loss
neither downgrad
market growth commentari impli softer market greater
share loss lead us materi revis estim
risk-reward still look unfavor lower price
target downgrad share underweight
revenu vs mse updat guidanc low end
prior rang expect recent sell-off creat
seemingli better risk-reward quarter commentari suggest
market growth would materi lower versu mid-teen
neg develop earlier downgrad equal-weight sever month
ago primarili center slower commerci traction clinic catalyst
void less differenti versu competit one highlight
invest thesi balanc headwind exposur one
mid-teen growth market med-tech updat market disclosur
add anoth overhang stori lead us materi lower
estim re-evalu dcf drive price target lower
downgrad share rel underweight equal-weight
see less upsid versu rest coverag
make sens market commentari market commentari like
biggest surpris quarter first time manag quantifi
lower unit volum growth manag impli healthcar
confer competitor share gain market revenu basi
result upgrad replac cycl driven
price/mix volum said even though expect market growth
slow competit product cycl anniversari manag commentari
suggest draconian view
skeptic issu account market believ
less differenti commerci execut failur may primari culprit
laid earlier downgrad discuss yesterday abbott
suggest limit price gain low mid singl
medic technolog unit state america
unless otherwis note metric base modelwar
consensu data provid thomson reuter estim
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
digit price increas prior convers stress
price/mix realli signific driver given market model exhibit
current suggest growth quarter manag
correct impli pt growth driven sole price
pt abbott recent perform somewhat support
thesi growth slow two
quarter burst anniversari price could also explain sharp
growth boston see new product howev
note compani suggest volum price
primari driver growth
share market comment manag suggest
return growth seen prior hf therapi surpris
believ opioid crisi need non drug therapi combat pain
novel platform market expand data driven market
acceler convinc fundament shift rapidli
dilig compani check requir confirm
view either market go grow slower compani
lose share consist prior downgrad thesi neither
outcom posit indic futur stock momentum
much market slow next year previous suggest
market growth would fall market anniversari
intelli wavewrit boston launch admittedli
saw growth low doubl digit upper teen upper singl
digit suggest sens volum low
prior view
earli thought bring revenu estim
reflect y/i growth vs prior triangul around
impli implic underli volum commentari given rep
hire traction quarter continu model net rep add next year
expect product pressur given trend re-
evalu market model estim abbott boston
conduct dilig item current market model
estim us franchis grow next year suggest bp
y/i share loss first time sinc us launch senza
anoth overhang downgrad underweight head quarter
thought expect low setup improv market
commentari like concern mani cornerston
construct thesi earlier downgrad equal-weight primarili center
slower commerci traction clinic catalyst void less
differenti see slower market growth addit factor
lead us lower estim re-evalu dcf drive price
target lower equat sale addit
neg disclosur model revis quarter behind us see
risk/reward skew downsid share head saluda data
nan think question market growth share
overhang share resolv earliest
data platform catalyst see come
earliest visibl intermedi term challeng
downgrad share rel underweight see less upsid versu
rest coverag pleas see exhibit model chang exhibit
risk downgrad see upsid risk
quarter compet product launch anniversari earli
platform upgrad could revit sale view month
enthusiasm around clinic data senza-pdn senza-nsrbp
data readout nevro could acquir given lower
valuat recent pick-up smid cap med-tech
pleas see exhibit reconcili result vs mse
price target deriv base busi discount
cash flow valuat assum oper margin
wacc termin growth rate yield
ad expans
share gain expans market growth stay low mid-teen
net share gainer addit make substanti
progress expans opportun
differenti slower market growth weigh share revenu growth
lose us share
competit respons creat headwind progress date low-hang
fruit futur uptak prove challeng market prove
sensit market clinic data materi lose share
market slow lead multipl contract
estim grow market
result competit share
pressur less differenti
manag commentari suggest
market growth slow materi
clinic data expand
key data pain diabet neuropathi
non-surg back come
suggest clinic catalyst void
interim
senza superior could risk later
year earli competitor data
pt ww share increas
revenu
pt us share increas
revenu
pt us market growth assum
pro rata share increas revenu
competit launch data on-going
risk achiev price
sale rep hire anniversari
competitor product potenti help
pdn senza-nsrbp
million except ep
sale
sale
sale
sale
sale
sale
accret redeem convert prefer stock redempt valu
dollar million except per share data
good sold
dollar million except per share data
dollar million except per share data
accumul comprehens loss
dollar million except per share data
non-cash loss extinguish debt
payment origin issu discount
provis doubt account
write-down inventori
unreal loss foreign currenc transact
purchas short-term invest
proce matur short-term invest
chang restrict cash
proce issuanc common stock underwritten public offer
proce issuanc convert note
convert note initi issuanc discount debt issuanc cost
proce issuanc warrant
purchas convert note hedg
repay debt
purchas common stock proce issuanc common stock stock option exercis
begin period
end period
sale
sale
chang work capit
sale
pv
weight averag capit wacc
equiti
margin debt
after-tax debt
pv free flow
pv termin valu
pv tax benefit
mv equiti invest
one year valu
total
present valu
pv
pv termin valu
one year valu
million
